Abbott and St. Jude to sell products to Terumo

SHARE Abbott and St. Jude to sell products to Terumo
abbotthq070114_3.jpg

Abbott Laboratories and St. Jude Medical Inc. have agreed to sell portions of their businesses to medical device maker Terumo Corp. for $1.12 billion in hopes that it will clear the way for their buyout deal. | File photo

Abbott Laboratories and St. Jude Medical Inc. have agreed to sell portions of their businesses to medical device maker Terumo Corp. for $1.12 billion in hopes that it will clear the way for their buyout deal.

North Chicago-based Abbott is buying St. Paul, Minnesota-based St. Jude for $19.3 billion, but the deal faces scrutiny by antitrust regulators. The medical device makers are shedding some units and products to meet regulatory approval for the deal to close.

The sale to Japan-based Terumo includes St. Jude’s Angio-SealT and FemosealT vascular closure products and Abbott’s Vado Steerable Sheath. Abbott will retain its vascular closure products, which include the Perclose ProGlide Suture-Mediated Closure System, StarClose SE Vascular Closure System and Prostar XL Percutaneous Vascular Surgical System.

Abbott expects the St. Jude buyout to close in the fourth quarter.

The Latest
In their home the threesome sleeps in one room, but the man’s dad isn’t comfortable with that arrangement.
The cafe’s new location will have hundreds of board games for visitors to play and serve food and drinks.
Cubs starter Jameson Taillon was charged with one run through 7 ⅓ innings
The boy was inside a car about 5:30 p.m. in the 8300 block of South Cottage Grove Avenue when someone approached him and fired shots, police said.